Double-blind, Multicenter Study to Assess the Efficacy of Bilateral

Status Completed

Clinical Trial Summary

The purpose of this study is to investigate the efficacy and safety of bilateral pallidal stimulation in patients with medically refractory primary cervical dystonia.

Clinical Trial Description

Primary cervical dystonia (CD) affects about 20-40/100.000 population. The disease is chronic and life-long. The therapy of choice are local intramuscular Botulinum Toxin injections given every three months. Oral medication such as anticholinergics or dopamine depleting drugs are usually of limited efficacy or their use is limited by intolerable side-effects. About 5-10% of CD patients develop neutralizing antibodies against Botulinum Toxin. Two previous controlled multicenter trials have shown the efficacy and safety of bilateral pallidal stimulation in patients with primary segmental and generalized dystonia (one study was performed by our group).

Following surgery, patients will be randomized 1:1 to verum or placebo stimulation for a period of three months. Primary outcome measure is the TWSTRS (Toronto Western Spasmodic Torticollis Rating Scale) - a validated and widely accepted physician-based outcome measure for cervical dystonia. The independent TWSTRS raters are movement disorders specialists unaware of the stimulation status (verum/placebo) and they compare the TWSTRS-score at baseline and 3-months follow-up. Our hypothesis is that stimulated patients will have a significantly better improvement of dystonia as compared to those without stimulation (placebo group).

After the 3-months period, all patients are unblinded and receive continuous effective stimulation by the implanted system. Regular follow-up visits are scheduled every 12 months for 5 years postoperatively to assess the long-term efficacy of pallidal stimulation. Side-effects are assessed in a standardized way and include the assessment of surgery-induced as well as stimulation-induced side-effects. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00148889
Study type	Interventional
Source	German Parkinson Study Group (GPS)
Contact
Status	Completed
Phase	Phase 3
Start date	July 2005
Completion date	April 2008

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03617367` - Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS)	Phase 3
Not yet recruiting	`NCT04057911` - A Trial of Non-invasive Stimulation in Cervical Dystonia	N/A
Withdrawn	`NCT02180139` - tDCS in Cervical Dystonia	N/A
Completed	`NCT00541905` - Daily Dystonia Practice - A Trial to Investigate NT 201, the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Cervical Dystonia	Phase 4
Unknown status	`NCT00418925` - Efficacy of Dronabinol for the Treatment of Cervical Dystonia	Phase 2
Not yet recruiting	`NCT05715138` - Comparison of Pallidal With Subthalamic Deep Brain Stimulation for Cervical Dystonia	N/A
Completed	`NCT02959645` - Assessment of Brain Activities in Cervical Dystonia
Completed	`NCT02131467` - Safety and Tolerability of Perampanel in Cervical Dystonia	Phase 1/Phase 2
Completed	`NCT03805152` - Abobotulinum Toxin and Neubotulinum Toxin Injection in Cerivical Dystonia	Phase 3
Completed	`NCT04949594` - Relief of Pain in Patients With Cervical Dystonia Through the Use of Transcutaneous Electric Nerve Stimulation (TENS)
Recruiting	`NCT01664013` - The Impact of Botulinum Toxin Treatment in Quality of Life of Cervical Dystonia Patients	Phase 4
Completed	`NCT00210431` - Post Marketing Surveillance Study of Dysport
Completed	`NCT00447772` - Study to Assess the Efficacy and Safety of Dysport® in Cervical Dystonia	Phase 3
Completed	`NCT05157100` - Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia	Phase 4
Completed	`NCT00257660` - Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia	Phase 3
Completed	`NCT05103202` - Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin
Terminated	`NCT00760318` - Keppra for Cervical Dystonia	Phase 2
Completed	`NCT00323765` - Plasticity in Cervical Dystonia	N/A
Completed	`NCT04171258` - Clinical Trial to Compare the Safety and Efficacy of Botulax® Versus Botox® in Patients With Cervical Dystonia	Phase 1
Completed	`NCT04849988` - A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Double-blind, Multicenter Study to Assess the Efficacy of Bilateral Pallidal Stimulation in Patients With Medically Refractory Primary Cervical Dystonia

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms